Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease
Lihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Inflammatory aspects of Alzheimer’s disease
Pablo Botella Lucena, Michael T. Heneka
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Closed Access | Times Cited: 25
Neuroinflammation in Alzheimer disease
Wiesje M. van der Flier, Wiesje M. van der Flier, Frank Jessen, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 18
VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
James P. Quinn, Savannah E. Kandigian, Bianca A. Trombetta, et al.
Brain Communications (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 79
Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research Center
María Victoria Fernández, Menghan Liu, Aleksandra Beric, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Decoding sTREM2: its impact on Alzheimer’s disease – a comprehensive review of mechanisms and implications
Cui Lin, Yu Kong, Qian Chen, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Pharmacokinetic analysis using single dilution assays: enhancing precision, reducing errors and increasing throughput
Saloumeh K Fischer, Xiang Xu, H Ji, et al.
Bioanalysis (2025), pp. 1-7
Closed Access
TREM2 risk variants and associated endophenotypes in alzheimer’s disease
Janna I.R. Dijkstra, Lisa Vermunt, Vikram Venkatraghavan, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
The late-onset Alzheimer’s disease risk factor RHBDF2 is a modifier of microglial TREM2 proteolysis
Georg Jocher, Gözde Özcelik, Stephan A. Müller, et al.
Life Science Alliance (2025) Vol. 8, Iss. 5, pp. e202403080-e202403080
Open Access
TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
Lianshuai Zhang, Xianyuan Xiang, Y. Li, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Research advances of tissue-derived extracellular vesicles in cancers
Wei Li, Jingyao Zhu, Jiayuan Li, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 3
Association of soluble TREM2 with Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
Ruiqi Wang, Yijun Zhan, Wenyan Zhu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3
A Reproducibility Focused Meta-Analysis Method for Single-Cell Transcriptomic Case-Control Studies Uncovers Robust Differentially Expressed Genes
Nathan Nakatsuka, Drew Adler, Longda Jiang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
TGF-β Signaling in Microglia: A Key Regulator of Development, Homeostasis and Reactivity
Lulin Li, Bryan Sun, Odette A. Harris, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2468-2468
Open Access | Times Cited: 2
Immunological alterations in patients with current and lifetime suicide ideation and attempts: Examining the relationship with depressive symptoms
Leandro Nicolás Grendas, Eugenio Antonio Carrera Silva, Romina Isabel Álvarez Casiani, et al.
Brain Behavior & Immunity - Health (2024) Vol. 38, pp. 100777-100777
Open Access | Times Cited: 1
Brain-Immune interactions: Implication for Cognitive impairments in Alzheimer's Disease and autoimmune disorders
Rashmi Kadam, Muskan Gupta, Orly Lazarov, et al.
Journal of Leukocyte Biology (2024)
Closed Access | Times Cited: 1
Association between a single‐nucleotide polymorphism of the angiotensin‐converting enzyme gene and susceptibility to systemic lupus erythematosus in the Hainanese population of China
Qi Zhang, Yanping Zhuang, Xuan Zhang, et al.
International Journal of Immunogenetics (2024) Vol. 51, Iss. 5, pp. 319-329
Open Access | Times Cited: 1
A genetic and proteomic comparison of key AD biomarkers across tissues
Thomas W. Marsh, Daniel Western, Jigyasha Timsina, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6423-6440
Open Access | Times Cited: 1
Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
Rafael Rivas‐Santisteban, Ana Muñoz, Jaume Lillo, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The Alzheimers Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states
Dalya R. Soond, Jessica D. Sun, Angie Yee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The late onset Alzheimer’s disease risk factor iRhom2/RHBDF2 is a modifier of microglial TREM2 proteolysis
Georg Jocher, Stephan A. Müller, Hung‐En Hsia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
TREM2 Risk Variants with Alzheimer Disease Differ in Rate of Cognitive Decline
Janna I.R. Dijkstra, Lisa Vermunt, Vikram Venkatraghavan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
TREM2 Risk Variants with Alzheimer’s Disease Differ in Rate of Cognitive Decline
Janna I.R. Dijkstra, Lisa Vermunt, Vikram Venkatraghavan, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top